TrialHuman vaccines & immunotherapeutics2021

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial.

Vu Dinh Thiem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.